Trial result ·
The Effect of Adding Dexmedetomidine to Modified Del Nido Cardioplegia Solution on Myocardial Protection in Children Undergoing Congenital Heart Defect Surgery - A Prospective, Randomized, Triple-Blind, Controlled Trial.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This trial looked at children having heart surgery for defects they were born with. During this surgery, the heart is stopped with a special fluid. The team tested adding a drug called dexmedetomidine to this fluid. The fluid was modified Del Nido cardioplegia. In all, 60 children took part. They were split by chance into groups of equal size. One group got the fluid with the drug added. The other group got the fluid with salt water. Key people in the trial did not know who got which fluid.
What they found
The authors say the heart was better guarded in the drug group. Children in the drug group had lower troponin I in the blood. This held at each time point after surgery. They had lower scores for drugs used to support the heart. They came off the breathing machine sooner. They also spent less time in intensive care. Other problems after surgery did not differ clearly between the groups.
What it means for patients
The authors conclude that the drug added to the fluid helped protect the heart. This was in children having surgery to repair heart defects. The abstract does not say how this may change care.
Why it is not certain yet
The trial had only 60 children. The abstract does not give results for creatine kinase-MB or lactate. It does not say how long the children were followed. It gives no details on side effects of the drug. Results from one trial need to be checked by others.
Source
The Effect of Adding Dexmedetomidine to Modified Del Nido Cardioplegia Solution on Myocardial Protection in Children Undergoing Congenital Heart Defect Surgery - A Prospective, Randomized, Triple-Blind, Controlled Trial.
PubMed · PMID 42981171We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Congenital heart disease publications